GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (CHIX:YPSNz) » Definitions » Return-on-Tangible-Equity

Ypsomed Holding AG (CHIX:YPSNZ) Return-on-Tangible-Equity : 25.60% (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ypsomed Holding AG Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Ypsomed Holding AG's annualized net income for the quarter that ended in Mar. 2024 was CHF83.6 Mil. Ypsomed Holding AG's average shareholder tangible equity for the quarter that ended in Mar. 2024 was CHF326.5 Mil. Therefore, Ypsomed Holding AG's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 25.60%.

The historical rank and industry rank for Ypsomed Holding AG's Return-on-Tangible-Equity or its related term are showing as below:

CHIX:YPSNz' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 2.28   Med: 19.4   Max: 23.9
Current: 23.9

During the past 13 years, Ypsomed Holding AG's highest Return-on-Tangible-Equity was 23.90%. The lowest was 2.28%. And the median was 19.40%.

CHIX:YPSNz's Return-on-Tangible-Equity is ranked better than
87.11% of 760 companies
in the Medical Devices & Instruments industry
Industry Median: 1.32 vs CHIX:YPSNz: 23.90

Ypsomed Holding AG Return-on-Tangible-Equity Historical Data

The historical data trend for Ypsomed Holding AG's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Return-on-Tangible-Equity Chart

Ypsomed Holding AG Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.10 2.28 10.59 19.26 23.51

Ypsomed Holding AG Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.53 12.11 22.44 22.60 25.60

Competitive Comparison of Ypsomed Holding AG's Return-on-Tangible-Equity

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Return-on-Tangible-Equity falls into.



Ypsomed Holding AG Return-on-Tangible-Equity Calculation

Ypsomed Holding AG's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=78.366/( (330.593+336.158 )/ 2 )
=78.366/333.3755
=23.51 %

Ypsomed Holding AG's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Sep. 2023 )(Q: Mar. 2024 )
=83.574/( (316.797+336.158)/ 2 )
=83.574/326.4775
=25.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Ypsomed Holding AG  (CHIX:YPSNz) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Ypsomed Holding AG Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG (CHIX:YPSNZ) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (CHIX:YPSNZ) Headlines

No Headlines